Michael Clancy#7220

Michael Clancy

Michael Clancy is a competition lawyer who focuses on providing clients with actionable, commercially-minded advice and solutions, allowing clients to manage complex internal and external challenges and achieve their objectives.
 
Michael works with clients in a range of industries and has extensive experience in the life sciences sector, where he advises clients on the competition law issues arising throughout the lifespan of a product, including:
 
Licensing & R&D Collaborations
Developing and implementing effective licensing and R&D collaboration arrangements that take into account the limits imposed by the competition laws on issues ranging from pricing control, trade management, information exchange, exclusive arrangements and any required approvals from competition authorities.

Pricing Strategies & Governance
Working closely with clients’ pricing and reimbursement teams to develop effective and compliant pricing strategies that address threats from competitors and allow successful agreements with payors and authorities. Michael also provides advice on internal and external pricing governance systems that allow clients to implement desired pricing strategies across different countries and regions.

Supply and Distribution
Working with clients to structure and implement compliant distribution systems intended to ensure the appropriate and adequate supply of products to patients in each country.

Compliance Tools
Developing effective compliance tools, tailored to the clients’ specific business, which allow in-house counsel to constructively advise and guide business teams on issues such as dawn raids, market definition, collection of market intelligence, industry associations and trade activities, competitive pricing, distribution and supply and late life cycle management.

Investigation Defense & Complaints
While the objective is always to help clients avoid legal issues and regulatory scrutiny, where legal challenges arise, Michael works with clients on proactive strategies intended to quickly resolve the issue or investigation. Michael also supports clients where necessary to take legal actions against competitors engaging in illegal activities.
Contributed to

1

Competition law in the pharmaceutical sector
Competition law in the pharmaceutical sector
Practice notes

This Practice Note covers the application of EU and UK competition law to common practices that take place within the pharmaceutical sector. After explaining the definition of market as it applies to the sector, it considers reverse payment patent settlements, pricing strategy, parallel trade, misleading conduct, misuse of regulatory procedures, R&D collaboration agreements as well as mergers and acquisitions.

Practice Area

Panel

  • Contributing Author

Qualified Year

  • 2004

Qualification

  • New York Bar (2004)

Education

  • Yale Law School (2003)

If you expected to see yourself on this page, click here.